Q32 Bio: Oppenheimer slashes price target on mixed trial results
Original source: https://www.investing.com/news/stock-market-news/q32-bio-oppenheimer-slashes-price-target–on-mixed-trial-results-3765273
Read More »Eliem therapeutics executive sells over $9,000 in company stock
Original source: https://www.investing.com/news/stock-market-news/eliem-therapeutics-executive-sells-over-9000-in-company-stock-93CH-3626567
Read More »Sanofi: gemeinsame Zulassung mit Regeneron Pharmaceuticals für Blockbuster Dupixent
Fortschritte bei Lungenerkrankungen könnten die Sanofi-Aktie (SAN) beflügeln! Jetzt Swingtrade starten? Sanofi (SAN) – FR0000120578 Rückblick Mit einem Kursverlust von knapp 2.5 Prozent in den vergangenen sechs Monaten bewegt sich…
Read More »Pro Research: Wall Street dives into Regeneron’s robust prospects
Original source: https://www.investing.com/news/stock-market-news/pro-research-wall-street-dives-into-regenerons-robust-prospects-93CH-3279303
Read More »Pro Research: Wall Street eyes Gilead’s strategic moves in biopharma
Original source: https://www.investing.com/news/stock-market-news/pro-research-wall-street-eyes-gileads-strategic-moves-in-biopharma-93CH-3263753
Read More »MYMX Up 70% Today But The Company Intends To De-List And Go Private Soon.
MYMX Saw One Of The Biggest Runs On The Market Today But The Company Is Going Private, And Is Likely Just Seeing A Mercy Pump, Before No Longer Publicly Trading. Mymetics…
Read More »KRTL Up 58.23% On News Of Permitted Approvals From The Treasury Department.
KRTL Up 58.23% Today After Tweet Revealing Permitted Approvals From The Treasury Department. KRTL Holding Group, Inc., (PINK:KRTL) saw one of the biggest one day gains in the market…
Read More »QBIO Up 188% On News That Granting Of A New U.S. Patent Is Likely.
QBIO Closed Up 188%, On News Of Likely Being Granted A New U.S. Patent. Q BioMed Inc., (OTCQB:QBIO) set itself apart as the strongest running penny stock on the…
Read More »BPTS Up 73.13% After Study Shows 44% Reduction In Risk Of Respiratory Failure To Severe Covid 19 Patients.
BPTS Up 73.13% After Study Shows 44% Reduction In Risk Of Respiratory Failure In Severe Covid 19 Patients. Biophytis (NASDAQ:BPTS) saw a huge close up 73.13% today after releasing…
Read More »Gilead Sciences – Zündet die Biotechnologie-Aktie jetzt die nächste Stufe?
Breakout Trading-Strategie Symbol: GILD ISIN: US3755581036 Rückblick: Gilead Sciences ist ein unabhängiges und weltweit operierendes Biotechnologie-Unternehmen. Kernkompetenz ist die Entwicklung von therapeutischen Lösungen für die Behandlung von lebensbedrohlichen Infektionskrankheiten. Die…
Read More »